The latest closing stock price for Evogene as of February 24, 2025 is 1.42.
An investor who bought $1,000 worth of Evogene stock at the IPO in 2010 would have $-985 today, roughly -1 times their original investment - a -26.00% compound annual growth rate over 14 years.
The all-time high Evogene stock closing price was 199.90 on December 12, 2013.
The Evogene 52-week high stock price is 10.40, which is 632.4% above the current share price.
The Evogene 52-week low stock price is 1.20, which is 15.5% below the current share price.
The average Evogene stock price for the last 52 weeks is 4.37.
An investor who bought $1,000 worth of Evogene stock at the IPO in 2010 would have $-985 today, roughly -1 times their original investment - a -26.00% compound annual growth rate over 14 years.
The all-time high Evogene stock closing price was 199.90 on December 12, 2013.
The Evogene 52-week high stock price is 10.40, which is 632.4% above the current share price.
The Evogene 52-week low stock price is 1.20, which is 15.5% below the current share price.
The average Evogene stock price for the last 52 weeks is 4.37.